文献速递复苏、休克与脓毒症心脑血管急症

院外心脏骤停中骨髓腔通路与静脉通路比较:复苏结局联盟持续胸外按压试验的洞察

Intraosseous versus intravenous access in patients with out-of-hospital cardiac arrest: Insights from the resuscitation outcomes consortium continuous chest compression trial.
PubMed 文献 · Resuscitation · 2018-11-01
一句话结论院外心脏骤停中尝试骨髓腔通路与较低持续自主循环恢复率相关(OR 0.80),但出院存活率与神经功能良好存活率校正后无差异。

本研究利用持续胸外按压试验数据,纳入19731例院外心脏骤停患者,比较尝试骨髓腔通路(3068例)与静脉通路(16663例)给药后的结局。未校正分析显示骨髓腔通路组出院存活率(4.6% vs 5.7%)、持续自主循环恢复率(17.9% vs 23.5%)和神经功能良好存活率(2.8% vs 4.2%)均较低。校正年龄、性别、初始心律、旁观者心肺复苏、公共场所、目击状态、急救反应和试验随机化集群后,出院存活率(OR 0.88,95%CI 0.72-1.09)和神经功能良好存活率(OR 0.87,95%CI 0.67-1.12)无差异,但持续自主循环恢复率仍较低(OR 0.80,95%CI 0.71-0.89)。作者结论认为需进一步研究明确院外心脏骤停的最佳通路选择。

要点

  • 校正混杂因素后,尝试骨髓腔通路与静脉通路相比,持续自主循环恢复率较低(OR 0.80,95%CI 0.71-0.89,p<0.001)。
  • 校正后出院存活率无差异:骨髓腔通路组 OR 0.88(95%CI 0.72-1.09,p=0.24)。
  • 校正后神经功能良好存活率无差异:骨髓腔通路组 OR 0.87(95%CI 0.67-1.12,p=0.29)。
  • 未校正出院存活率骨髓腔通路组4.6% vs 静脉通路组5.7%(p=0.01),校正后差异未达统计学显著。
  • 骨髓腔通路组患者更年轻、女性更多,首次通路建立和首次给药时间略快。

适用人群与场景

  • 院外心脏骤停患者,数据来自持续胸外按压试验,共19731例。
  • 尝试骨髓腔通路者3068例,尝试静脉通路者16663例。

研究设计与关键结果

  • 研究类型为利用持续胸外按压试验数据的分析,纳入19731例院外心脏骤停患者,比较尝试骨髓腔通路(3068例)与静脉通路(16663例)给药后的结局。
  • 未校正结局:出院存活率骨髓腔通路组4.6% vs 静脉通路组5.7%(p=0.01);持续自主循环恢复率17.9% vs 23.5%(p<0.001);神经功能良好存活率2.8% vs 4.2%(p<0.001)。
  • 校正年龄、性别、初始心律、旁观者心肺复苏、公共场所、目击状态、急救反应和试验随机化集群后,出院存活率无差异(OR 0.88,95%CI 0.72-1.09,p=0.24)。
  • 校正后神经功能良好存活率无差异(OR 0.87,95%CI 0.67-1.12,p=0.29)。
  • 校正后骨髓腔通路仍与较低的持续自主循环恢复率相关(OR 0.80,95%CI 0.71-0.89,p<0.001)。
  • 骨髓腔通路组患者更年轻、更常为女性,首次通路建立时间和首次给药时间略快。

证据类型、等级与局限

  • 证据类型:基于持续胸外按压试验数据的分析。
  • 局限:原文未报告局限性。
  • 作者结论:院外心脏骤停中尝试骨髓腔通路与较差的自主循环恢复率相关,但存活率无差异;需进一步研究阐明院外心脏骤停患者的最佳通路选择。

对床旁实践的改变

  • 原文结论提示,在院外心脏骤停中尝试骨髓腔通路与较低的持续自主循环恢复率相关,但出院存活率和神经功能良好存活率校正后无差异。
  • 作者认为需进一步研究以阐明院外心脏骤停患者的最佳通路选择。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

AIM: To examine outcomes associated with intraosseous access route attempt for delivery of medications during out-of-hospital cardiac arrest (OHCA) resuscitation.

METHODS: Using data from the Continuous Chest Compression trial, we examined rates of survival to hospital discharge, sustained return of spontaneous circulation (ROSC), and survival with favorable neurological function among patients with intraosseous and intravenous access attempts after adjusting for age, sex, initial rhythm, bystander cardiopulmonary resuscitation, public location, witnessed status, EMS response and trial randomization cluster.

RESULTS: Among 19,731 patients, intraosseous access was attempted in 3068 patients and intravenous access in 16,663 patients respectively. Patients in whom intraosseous access was attempted were younger, more often female, and had marginally faster times to initial access and to initial drug administration. Unadjusted outcomes were significantly lower in patients with attempted intraosseous access compared with intravenous access: (4.6% vs. 5.7%, p = 0.01) for survival to discharge, (17.9% vs. 23.5%, p < 0.001) for sustained ROSC and (2.8% vs. 4.2%, p < 0.001) for survival with favorable neurological function. After adjustment, there were no differences in hospital survival (OR, 0.88, 95% CI 0.72-1.09, p = 0.24) or survival with favorable neurological function (OR, 0.87, 95% CI 0.67-1.12, p = 0.29) in patients with intraosseous access attempt (vs. intravenous access). However, intraosseous access continued to associate with lower rates of sustained ROSC (OR, 0.80, 95% CI 0.71 - 0.89, p < 0.001).

CONCLUSIONS: Among patients with OHCA, intraosseous access attempt was associated with worse ROSC rates but no difference in survival. Further studies are necessary to elucidate the optimal access route among OHCA patients.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Mody P, Brown SP, Kudenchuk PJ, et al. Intraosseous versus intravenous access in patients with out-of-hospital cardiac arrest: Insights from the resuscitation outcomes consortium continuous chest compression trial. Resuscitation. 2018. PMID: 30391366. doi:10.1016/j.resuscitation.2018.10.031

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。